BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3180136)

  • 21. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
    Qian GX; Fu SM; Solanki DL; Rai KR
    J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human lymphocyte and monocyte lysis of tumor cells mediated by a mouse/human IgG1 chimeric monoclonal antibody.
    Shaw DR; Harrison G; Sun LK; Shearman C; Ghrayeb J; McKinney S; Daddona PE; LoBuglio AF
    J Biol Response Mod; 1988 Apr; 7(2):204-11. PubMed ID: 3361351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
    J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of anti-malignin antibody and malignin in 1,026 cancer patients and controls: relation of antibody to survival.
    Bogoch S; Bogoch ES; Fager CA; Harris JH; Ambrus JL; Lux WE; Ransohoff JA
    J Med; 1982; 13(1-2):49-69. PubMed ID: 6750020
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of nuclear proteins of several human tumors and normal cells by two-dimensional gel electrophoresis.
    Wu BC; Spohn WH; Busch H
    Cancer Res; 1981 Jan; 41(1):336-42. PubMed ID: 7448773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.
    David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R
    Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
    Salinas FA; Wee KH; Ceriani RL
    Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies.
    Adams DJ; Hajj H; Edwards DP; Bjercke RJ; McGuire WL
    Cancer Res; 1983 Sep; 43(9):4297-301. PubMed ID: 6871865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR).
    Ghebrehiwet B
    J Immunol; 1986 Jul; 137(2):618-24. PubMed ID: 3487576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of variable regions of an antibody that reacts with the soluble fraction of human liver cells and its possible value in chronic liver disease.
    Saito H; Tada S; Ebinuma H; Atsukawa K; Masuda T; Inagaki Y; Tsuchimoto K; Morizane T; Ishii H
    Hepatology; 1996 Jun; 23(6):1498-506. PubMed ID: 8675170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
    Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
    Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of patients with cancer by monoclonal antibody directed to lactoneotetraosylceramide (paragloboside).
    Myoga A; Taki T; Arai K; Sekiguchi K; Ikeda I; Kurata K; Matsumoto M
    Cancer Res; 1988 Mar; 48(6):1512-6. PubMed ID: 3345524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
    Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
    Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T; Yagita H; Hashimoto Y
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium.
    Ornstein DK; Englert C; Gillespie JW; Paweletz CP; Linehan WM; Emmert-Buck MR; Petricoin EF
    Clin Cancer Res; 2000 Feb; 6(2):353-6. PubMed ID: 10690510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC.
    Fukushima N; Nalbandian G; Van De Water J; White K; Ansari AA; Leung P; Kenny T; Kamita SG; Hammock BD; Coppel RL; Stevenson F; Ishibashi H; Gershwin ME
    Hepatology; 2002 Dec; 36(6):1383-92. PubMed ID: 12447863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.